Voahangy Andrianaivoarimanana
Overview
Explore the profile of Voahangy Andrianaivoarimanana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
393
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Parany M, Stenseth N, Rasoamalala F, Rahelinirina S, Rahajandraibe S, Andrianaivoarimanana V, et al.
Integr Zool
. 2025 Jan;
PMID: 39806930
Plague, a zoonotic disease caused by Yersinia pestis, remains a major public health threat in several parts of the world, including Madagascar. Factors underlying long-term persistence and emergence of the...
2.
Randremanana R, Raberahona M, de Dieu Randria M, Bourner J, Zadonirina G, Razananaivo H, et al.
Trials
. 2024 Jul;
25(1):457.
PMID: 38970065
This article reports an update to the protocol of the IMASOY trial, which was prospectively registered on clinicaltrials.gov (NCT04110340) in October 2019.
3.
Randriantseheno L, Andrianaivoarimanana V, Pizarro-Cerda J, Wagner D, Rajerison M
PLoS Negl Trop Dis
. 2024 Jun;
18(6):e0012252.
PMID: 38935608
Background: Plague, a zoonotic disease caused by Yersinia pestis, was responsible for 3 historical human pandemics that killed millions of people. It remains endemic in rodent populations in Africa, Asia,...
4.
Andrianaivoarimanana V, Savin C, Birdsell D, Vogler A, Le Guern A, Rahajandraibe S, et al.
Emerg Infect Dis
. 2024 Jan;
30(2):289-298.
PMID: 38270131
Pneumonic plague (PP) is characterized by high infection rate, person-to-person transmission, and rapid progression to severe disease. In 2017, a PP epidemic occurred in 2 Madagascar urban areas, Antananarivo and...
5.
Shattock R, Andrianaivoarimanana V, McKay P, Randriantseheno L, Murugaiah V, Samnuan K, et al.
Front Microbiol
. 2023 Nov;
14:1247041.
PMID: 38029221
Mice were immunized with a combination of self-amplifying (sa) RNA constructs for the F1 and V antigens of at a dose level of 1 μg or 5 μg or with...
6.
Esquivel Gomez L, Savin C, Andrianaivoarimanana V, Rahajandraibe S, Randriantseheno L, Zhou Z, et al.
PLoS Negl Trop Dis
. 2023 May;
17(5):e0010362.
PMID: 37126517
Background: Plague is a zoonotic disease caused by the bacterium Yersinia pestis, highly prevalent in the Central Highlands, a mountainous region in the center of Madagascar. After a plague-free period...
7.
Ten Bosch Q, Andrianaivoarimanana V, Ramasindrazana B, Mikaty G, Rakotonanahary R, Nikolay B, et al.
PLoS Biol
. 2022 Aug;
20(8):e3001736.
PMID: 35969599
During outbreaks, the lack of diagnostic "gold standard" can mask the true burden of infection in the population and hamper the allocation of resources required for control. Here, we present...
8.
Andrianaivoarimanana V, Randriantseheno L, Moore K, Walker N, Lonsdale S, Kempster S, et al.
Immunother Adv
. 2022 Aug;
1(1):ltab020.
PMID: 35919741
Two monoclonal antibodies directed to the V antigen of have been tested for protective efficacy in a murine model of bubonic plague. Mice were infected with a current clinical isolate...
9.
Rakotondrasoa A, Andrianonimiadana L, Rahajandraibe S, Razafimahatratra S, Andrianaivoarimanana V, Rahelinirina S, et al.
Sci Rep
. 2022 Apr;
12(1):6871.
PMID: 35477743
Klebsiella pneumoniae can lead to a wide range of diseases including pneumonia, bloodstream and urinary tract infections. During a short period of a pulmonary plague epidemic in October 2017 in...
10.
Deatherage Kaiser B, Birdsell D, Hutchison J, Thelaus J, Jenson S, Andrianaivoarimanana V, et al.
Front Med (Lausanne)
. 2022 Feb;
9:821071.
PMID: 35223919
Antimicrobial resistance (AMR) is a well-recognized, widespread, and growing issue of concern. With increasing incidence of AMR, the ability to respond quickly to infection with or exposure to an AMR...